Skip to main content
↑

Tackling Transthyretin Amyloid Cardiomyopathy

  1. Home
  2. Tackling Transthyretin Amyloid Cardiomyopathy

This learning module has been supported by an unrestricted educational grant funded by Pfizer.
Pfizer has had no involvement with the content of this learning module due to the nature of the arm’s length grant funding.

 

 

 

Register Today

Keep up to date with the CVRMUK

The CVRMUK releases monthly newsletters to keep members updated on our ongoing activities.  Sign up to keep in touch or follow us on social media.